Samsung Bioepis Co., Ltd.
Clinical trials sponsored by Samsung Bioepis Co., Ltd., explained in plain language.
Now part of
Samsung Biologics Co., Ltd.
207940
KRX
A biopharmaceutical company developing and manufacturing biosimilars.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a copycat drug match the real thing? a trial puts ixekizumab to the test Results expected Jun 2027 (estimated)